MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection

Bibliographic Information
Authors: Megahed F.; Tabll A.; Atta S.; Ragheb A.; Smolic R.; Petrovic A.; Smolic M.
Journal: Medicina (Lithuania)
Publisher: MDPI
Publication Date: 15 January 2023
Volume / Issue: Volume 59 / Issue 1
Article No.: 173
ISSN: 1010660X
Scopus: View on Scopus
PubMed: 36676797
Document Type: Review
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Megahed F., Nucleic Acid Research Department, Genetic Engineering and Biotechnological Research Institute (GEBRI), City for Scientific Researches and Technological Applications (SRTA-City), Alexandria, 21934, Egypt; Tabll A., Microbial Biotechnology Department, National Research Centre, Giza, 12622, Egypt, Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, 11517, Egypt; Atta S., Department of Immunology, Theodor Bilharz Research Institute, Cairo, 12411, Egypt; Ragheb A., Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, 11517, Egypt; Smolic R., Faculty of Dental Medicine and Health Osijek, University of Osijek, Crkvena 21, Osijek, 31000, Croatia; Petrovic A., Faculty of Dental Medicine and Health Osijek, University of Osijek, Crkvena 21, Osijek, 31000, Croatia; Smolic M., Faculty of Dental Medicine and Health Osijek, University of Osijek, Crkvena 21, Osijek, 31000, Croatia
Abstract
A MicroRNA (miRNA) is defined as a small molecule of non-coding RNA (ncRNA). Its molecular size is about 20 nucleotides (nt), and it acts on gene expression’s regulation at the post-transcription level through binding to the 3’untranslated regions (UTR), coding sequences, or 5’UTR of the target messenger RNAs (mRNAs), which leads to the suppression or degradation of the mRNA. In recent years, a huge evolution has identified the origin and function of miRNAs, focusing on their important effects in research and clinical applications. For example, microRNAs are key players in HCV infection and have important host cellular factors required for HCV replication and cell growth. Altered expression of miRNAs affects the pathogenicity associated with HCV infection through regulating different signaling pathways that control HCV/immunity interactions, proliferation, and cell death. On the other hand, circulating miRNAs can be used as novel biomarkers and diagnostic tools for HCV pathogenesis and early therapeutic response. Moreover, microRNAs (miRNA) have been involved in hepatitis B virus (HBV) gene expression and advanced antiviral discovery. They regulate HBV/HCV replication and pathogenesis with different pathways involving facilitation, inhibition, activation of the immune system (innate and adaptive), and epigenetic modifications. In this short review, we will discuss how microRNAs can be used as prognostic, diagnostic, and therapeutic tools, especially for chronic hepatitis viruses (HBV and HCV), as well as how they could be used as new biomarkers during infection and advanced treatment. © 2023 by the authors.
Keywords
biomarkers; diagnosis; hepatitis B virus; hepatitis C virus; microRNAs; Hepatitis B; Hepatitis C; Humans; biological marker; microRNA; genetics; human; metabolism
Citation Information
Scopus Citations: 9
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
